David focuses his practice on patent prosecution, strategic intellectual property counseling, and due diligence for life science industries. He has designed global patent strategies in the field of pharmaceuticals and biotechnology, and managed large patent portfolios for a variety of clients. David’s clients range from international corporations, mid-sized biotech companies, to venture capital funded startups.
David has handled matters in a numerous technology areas, including cancer therapies, genome technologies, gene therapies, antibody drugs, personalized medicine, RNA therapeutics, diagnostic methods, and medical devices. By identifying each client’s technology strengths and business goals, David provides customized and creative legal solutions.
Prior to joining the firm, David served as a partner and the co-lead of the life sciences group at a U.S. law firm.
